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K6PC-5, a Direct Activator of Sphingosine Kinase 1,
Promotes Epidermal Differentiation Through
Intracellular Ca2þ Signaling
Jeong Hee Hong1,6, Jong-Kyung Youm2,3,6, Mi Jung Kwon3, Byeong Deog Park3, Yong-Moon Lee4,
Syng-Ill Lee1, Dong Min Shin1 and Seung Hun Lee2,5
Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, regulates multiple cellular responses such
as Ca2þ signaling, growth, survival, and differentiation. Because sphingosine kinase (SphK) is the enzyme
directly responsible for production of S1P, many factors have been identified that regulate its activity and
subsequent S1P levels. Here we synthesized a previously unidentified SphK activator, K6PC-5, and have studied
its effects on intracellular Ca2þ signaling in HaCaT cells and epidermal differentiation in murine skin. K6PC-5, a
hydrophobic compound chemically named N-(1,3-dihydroxyisopropyl)-2-hexyl-3-oxo-decanamide, activated
SphK (obtained from C57BL/6 murine blood and F9-12 cell lysates) in a dose-dependent manner. K6PC-5 induced
both intracellular Ca2þ concentration ([Ca2þ ]i) oscillations in HaCaT cells and Ca
2þ mobilization in hairless
mouse epidermis. Both dimethylsphingosine (DMS) and dihydroxysphingosine (DHS), SphK inhibitors, and
transfection of SphK1-siRNA blocked K6PC-5-induced increases in [Ca2þ ]i. The K6PC-5-induced [Ca
2þ ]i
oscillations were dependent on thapsigargin-sensitive Ca2þ stores and Ca2þ entry, but independent of the
classical phospholipase C-mediated pathway. In addition, K6PC-5 enhanced the expression of involucrin and
filaggrin, specific differentiation-associated marker proteins in HaCaT cells, whereas transfection of SphK1-
siRNA blocked the increase of involucrin. Topical K6PC-5 also enhanced the expression of involucrin, loricrin,
filaggrin, and keratin 5 in intact murine epidermis. Finally, topical K6PC-5 inhibited epidermal hyperplasia by
exerting antiproliferative effects on keratinocytes in murine epidermis. These results suggest that K6PC-5 acts to
regulate both differentiation and proliferation of keratinocytes via [Ca2þ ]i responses through S1P production.
Thus, regulation of S1P levels may represent a novel approach for treatment of skin disorders characterized by
abnormal differentiation and proliferation, such as atopic dermatitis and psoriasis.
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INTRODUCTION
Sphingosine-1-phosphate (S1P) is derived from sphingosine,
and represents a potent bioactive sphingolipid metabolite.
S1P acts as a multifunctional mediator of a variety of cellular
responses, including Ca2þ mobilization, proliferation, survival,
motility, and differentiation (reviewed by Spiegel and Milstien,
2003). S1P functions as both an extracellular ligand for a family
of five G-protein-coupled receptors and an intracellular second
messenger. S1P receptors regulate many physiological and
pathophysiological processes, such as vascular maturation,
cardiac development, angiogenesis, immunity, and cell migra-
tion (Spiegel and Milstien, 2003; Sanchez and Hla, 2004). S1P
also shows a universal Ca2þ signaling role through receptor-
dependent and independent pathways (Meyer zu Heringdorf,
2004). Cellular levels of S1P are tightly regulated in a spatio-
temporal manner both through synthesis, catalyzed by
sphingosine kinases (SphKs), and degradation by S1P lyase
and specific S1P phosphohydrolases (Stunff et al., 2004). Two
SphK isoforms, SphK1 and SphK2, are known to regulate the
relative levels of S1P, sphingosine, and ceramide in the
sphingolipid metabolic pathway (Kohama et al., 1998; Liu
et al., 2000; Stunff et al., 2004).
As SphK is directly responsible for production of S1P,
many factors have been identified that alter its activity
and regulate subsequent S1P levels (Maceyka et al., 2002;
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Taha et al., 2006). For example, SphK is activated by ligands
of G-protein-coupled receptors (Meyer zu Heringdorf et al.,
1998; Alemany et al., 1999, 2000; Gordon et al., 2000;
Young et al., 2000; Blaukat and Dikic, 2001; Misasi et al.,
2001; van Koppen et al., 2001), including S1P itself (Meyer
zu Heringdorf et al., 2001), agonists of growth factor-receptor
tyrosine kinases (Olivera and Spiegel, 1993; Edsall et al.,
1997; Meyer zu Heringdorf et al., 1999; Shu et al., 2002),
cross-linking of immunoglobulin receptors (Melendez et al.,
1998; Prieschl et al., 1999; Chuang et al., 2000), and the
endogenous ganglioside GM1 (Wang et al., 1996). Although
in some cases the mechanisms are unknown, many other
biologically active agents also activate SphK, including
estrogen (Sukocheva et al., 2003), tumor necrosis factor-a
(Xia et al., 1998), vitamin D3 (Kleuser et al., 1998), phorbol
ester (Mazurek et al., 1994; Buehrer et al., 1996), aluminum
fluoride (AlF4) (Alemany et al., 1999), serum (Taha et al.,
2006), and oxidized low-density lipoprotein (Auge´ et al.,
1999). To date, there are no reports to demonstrate a
chemically induced, direct activation of SphK. Although 12-
O-tetradecanoylphorbol-13-acetate showed direct effect on
SphK activation in total lysate and fractionated lysates of
Balb/c 3T3 fibroblasts, it is unclear whether this upregluation
of SphK occurs through direct SphK activation by the phorbol
ester, or through an enhanced transcription of SphK (Mazurek
et al., 1994). In this study, we suggest that a newly
synthesized K6PC-5 exerts direct SphK activation and
subsequent S1P-mediated Ca2þ regulation in keratinocytes.
S1P is an evolutionarily conserved Ca2þ -signaling mole-
cule in yeast, plants, and mammals, that uses specific Ca2þ
signaling to initiate diverse cellular responses (Spiegel and
Milstien, 2003). Acting as an agonist at G-protein-coupled
receptor, S1P increases the intracellular Ca2þ concentration
([Ca2þ ]i) through the classical phospholipase C (PLC)-
dependent pathway, as well by PLC-independent pathways
such as intracellularly activated SphK. Intracellular S1P also
mobilizes Ca2þ from intracellular stores by an as yet
unknown mechanism that might involve a novel Ca2þ
channel (Meyer zu Heringdorf, 2004). These PLC-independent
pathways do not include G-protein-coupled S1P receptors,
and Ca2þ signaling by many agonists requires SphK-mediated
S1P production. We suggest that a direct activator of SphK
may help to resolve these outstanding issues regarding the
relationship of intra- and extracellular S1P targets.
In mammalian skin, Ca2þ serves as a regulator for
keratinocyte proliferation and differentiation as well as a
signaling molecule for epidermal permeability barrier home-
ostasis. It is well established that Ca2þ can potentially induce
keratinocyte differentiation and repress cell growth (Hen-
nings et al., 1980; Hennings and Holbrook, 1983). In
addition, Ca2þ is an important signal that facilitates repair
of barrier function following acute injury (Lee et al., 1992).
Manggau et al. (2001) reported that 1a, 25-dihydroxyvitamin
D3 protects keratinocytes from apoptosis induced by cer-
amides, UV irradiation, or tumor necrosis factor-a, and
additionally this cytoprotection is mediated via formation of
S1P. More recently, Vogler et al. (2003) reported that all five
S1P receptors are expressed in keratinocytes, and that S1P
enhances differentiation of keratinocytes and protects the
cells from programmed cell death.
Most factors related to SphK activation regulate the activity
of SphK and the production of S1P by extracellular stimuli
targeting plasma membrane receptors. Recently, we synthe-
sized a new compound, K6PC-5, as an SphK activator, that
directly activates SphK. In this study, we investigate
intracellular Ca2þ signaling by K6PC-5 through its direct
effects on SphK activity in HaCaT cells, and determine its
effects on epidermal differentiation in murine skin.
RESULTS
K6PC-5 activates SphK in both murine blood and F9-12 cells
K6PC-5 is a hydrophobic compound containing a ketone
group, two hydroxy groups, two short alkyl groups, and an
amide linkage, characterized as a ‘‘pseudo-ceramide’’ back-
bone with a chemical name of N-(1,3-dihydroxyisopropyl)-2-
hexyl-3-oxo-decanamide. The origin of K6PC-5 is a bioactive
short-chain pseudoceramide that we synthesized and se-
lected for its effects on keratinocyte differentiation (Kwon
et al., 2007). K6PC-5 directly activated SphK obtained from
mouse blood in a dose-dependent manner (Figure 1a). C17-
sphingosine (C17-Sph) was used as the substrate for SphK,
and the production of C17-S1P was analyzed by high-
performance liquid chromatography with fluorescence
detection. Whole blood showed significant SphK activity as
reported previously (Venkataraman et al., 2006), with K6PC-
5 enhancing production of C17-S1P by 30% compared with
the control. Venkataraman et al. (2006) also demonstrated
non-detectable SphK activity in SphK1-knockout mouse
plasma, with approximately a corresponding 65% reduction
in S1P levels. Together, these results suggest that K6PC-5 has
a direct effect on SphK1 activity.
K6PC-5 also activated SphK in lysates from F9-12 mouse
embryonic carcinoma cells in a dose-dependent manner
(Figure 1b). The F9-12 cells lack S1P lyase and overexpress
SphK1 (Kariya et al., 2005). K6PC-5-induced SphK activation
was significantly inhibited by N,N-dimethylsphingosine
(DMS), an SphK inhibitor. These results also suggest that
K6PC-5 has a direct effect on SphK1 activity since possible
effects of blood factors on SphK activation are excluded by
the F9-12 cell lysates.
K6PC-5 induces [Ca2þ ]i oscillations in HaCaT cells
To confirm whether SphK-mediated S1P production by K6PC-
5 induces [Ca2þ ]i signaling as a result of the action
mechanism, we characterized the Ca2þ signals induced by
10–100 mM K6PC-5 in intact HaCaT keratinocytes. [Ca2þ ]i
oscillations were induced by K6PC-5 concentrations X25 mM
(Figure 2a). In addition, the percentage of responding cells
was dependent on K6PC-5 concentrations, that is,
10.3±1.5% at 25mM (n¼ 9); 47.9±15.6% at 50 mM (n¼ 9);
and 94.4±7.95% at 100mM (n¼ 12) (Figure 2c). However,
the amplitude of the spikes was unaffected by the K6PC-5
concentration in the range of 25–100 mM, while a spike-
plateau response was observed at a K6PC-5 concentration of
100mM. In addition, the K6PC-5-induced [Ca2þ ]i oscillations
were reversible (Figure 2b). The average lag time between
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K6PC-5 exposure and the generation of [Ca2þ ]i responses
was 1.5±1.0 minutes. Since 50 mM K6PC-5 did not induce
cell death (data not shown) and generally produced reliable
[Ca2þ ]i oscillations, this concentration was used to analyze
the mechanism by which K6PC-5 induced [Ca2þ ]i signaling.
Exogenous S1P also induced [Ca2þ ]i oscillations in a dose-
dependent manner (data not shown). These results reveal that
K6PC-5 induces [Ca2þ ]i oscillations in HaCaT cells.
K6PC-5-induced [Ca2þ ]i oscillations involve SphK1 activation
in HaCaT cells
S1P is a highly bioactive lipid that exerts numerous biological
effects both intracellularly as a second messenger and
extracellularly by binding to specific G-protein-coupled
receptors of the endothelial differentiation gene family
(Johnson et al., 2003). Intracellular S1P is generated by
SphK-dependent phosphorylation of sphingosine. Although
intracellular targets for S1P have yet to be identified, the
production of intracellular S1P, but not IP3, mobilizes
intracellular [Ca2þ ]i (Meyer zu Heringdorf et al., 2003). To
clarify the possibility that K6PC-5-activated [Ca2þ ]i oscilla-
tions and intracellular S1P levels are related, we used potent
SphK inhibitors, DMS and DL-threo-dihydrosphingosine
(DHS). Both DMS and DHS partially inhibited K6PC-5-
mediated [Ca2þ ]i oscillations (Figure 3a, n¼ 6).
The Ca2þ -signaling mechanism of K6PC-5 was further
investigated by using small interfering RNA (siRNA) to
examine the functional consequences of depletion of SphK1.
Transfection of siRNA-psiSTRIKE-SphK1 suppressed the ex-
pression of mRNA and the protein level of SphK1 (Figure 3b,
n¼3). mRNA levels of transfected cells were double checked
on both the first and sixth selections with G-418. We
determined the protein level for SphK1 in cells after the sixth
round of selection (Figure 3b), because there was no
distinguishable change of protein levels of SphK1 in the first
selection. In addition, [Ca2þ ]i responses were measured in
cells from the third to the sixth selection. As shown in
Figure 3c, siRNA-psiSTRIKE-SphK1 blocked [Ca2þ ]i responses
(44 cells, n¼6, third selection), whereas [Ca2þ ]i oscillations
persisted in control (scrambled)-psiSTRIKE-SphK1-transfected
cells (31 cells, n¼ 6, third selection). To confirm these results,
we measured the [Ca2þ ]i responses in hMGFP-transfected
cells. siRNA-hMGFP-SphK1 transfected cells were also
blocked the [Ca2þ ]i responses (data not shown). Therefore,
the effects of K6PC-5 on Ca2þ oscillations are S1P-
dependent, through activity of SphK1.
Numerous studies also have shown that S1P-induced
increases in [Ca2þ ]i signals involve a Gi-PLC-mediated
pathway (Muraki and Imaizumi, 2001; Young and Nahorski,
2002). To determine whether K6PC-5-induced [Ca2þ ]i
responses involve a Gi-PLC-mediated pathway, cells were
pretreated with pertussis toxin, a Gi inhibitor (El-Shewy et al.,
2006). Pertussis toxin inhibited the Ca2þ responses induced
by exogenous S1P, whereas the K6PC-5-induced [Ca2þ ]i
responses were not affected (Figure 3d, n¼4). Together,
these results suggest that K6PC-5-induced [Ca2þ ]i oscilla-
tions involve generation of intracellular S1P by activation of
SphK1, corresponding with the direct effect of K6PC-5 on
SphK1 activity in mice blood (cf. Figure 1).
K6PC-5-induced [Ca2þ ]i oscillations are dependent on both
thapsigargin-sensitive Ca2þ stores and Ca2þ entry, but not the
PLC/IP3 pathway, in HaCaT cells
G-protein-coupled agonists induce two types of [Ca2þ ]i
oscillations, that is, those acutely dependent on Ca2þ influx
and those largely involving Ca2þ release and reuptake
into the endoplasmic reticulum, with minimal contribution
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Figure 1. K6PC-5 activated SphK in mice blood and F9-12 cells. Whole
blood of C57BL/6 mice was incubated with C17-Sph and K6PC-5 was added
under diluting in half from 500 mM. The black circles in order are 0mM (vehicle
only), 33.25, 62.5, 125, 250, 500mM K6PC-5 (a). F9-12 cell lysates were
incubated with C17-Sph and K6PC-5 (b). 50 mM DMS was incubated with
K6PC-5 in to confirm the inhibitory effect on SphK in F9-12 cell lysates and
C17-Sph system (c). NC, normal control as the vehicle. All data have
significant P-values less than 0.001 compared with the vehicle control.
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of Ca2þ influx (Kiselyov et al., 2003). To identify the source
of [Ca2þ ]i mobilization by K6PC-5, Ca
2þ was removed from
physiological salt solution (PSS). Depletion of intracellular
Ca2þ by thapsigargin (Tg), a specific inhibitor of the
sarcoplasmic endoplasmic reticulum Ca2þ ATPase (SERCA)
pump (Hong et al., 2004), prevented K6PC-5-induced
[Ca2þ ]i oscillations (Figure 4a; n¼ 25). In a paired experi-
ment, we found that depletion of the endoplasmic reticulum
by stimulation with 100 mM K6PC-5 in the absence of external
Ca2þ prevented the Ca2þ influx caused by 1 mM Tg (n¼ 25).
These results indicate that intracellular Ca2þ stores respon-
sible for K6PC-5-induced [Ca2þ ]i oscillations are Tg-sensi-
tive. Treatment of cells with 100 mM K6PC-5, with or without
external Ca2þ , revealed that K6PC-5-induced Ca2þ ampli-
tude decreased approximately 12% in the absence of Ca2þ
(n¼5). To further delineate the source of [Ca2þ ]i increase,
cells were first treated with 50 mM K6PC-5 for 10 minutes in
the presence of external Ca2þ , followed by Ca2þ -free PSS for
15 minutes. Re-addition of Ca2þ failed to yield [Ca2þ ]i
oscillations in these cells (Figure 4b). These results suggested
that extracellular Ca2þ also is a source for K6PC-5-induced
[Ca2þ ]i oscillations. To examine whether K6PC-5-induced
[Ca2þ ]i signal occurs through plasma membrane Ca
2þ
channels, cells were exposed to 75 mM 2-aminoethoxydiphe-
nyl borate (2-APB) and 1 mM gadolinium (Gd3þ ) (non-
selective Ca2þ channel blockers). Both 2-APB (n¼17) and
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Figure 2. K6PC-5 induced [Ca2þ ]i oscillations in HaCaT cells. HaCaT cells were loaded with fura-2 as described under Materials and Methods, and changes in
[Ca2þ ]i were measured by ratiometric fluorescence imaging. Cells were exposed to 10, 25, 50, or 100 mM K6PC-5 (a). 50 mM K6PC-5 was applied, washed out
with PSS, and re-applied (b). The percentage of responding cells to K6PC-5 was calculated (c). Results are depicted as mean±SE.
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Gd3þ (n¼ 16) prevented the generation of [Ca2þ ]i oscilla-
tions by K6PC-5 (Figure 4c). To determine the role of PLC in
K6PC-5-mediated [Ca2þ ]i oscillations, we next tested the
effect of U73122, a PLC blocker, and as control its inactive
analog U73343 (n¼ 5). As shown in Figure 4d, U73122, but
not U73343, prevented only exogenous S1P-evoked [Ca2þ ]i
oscillations, with no effect on K6PC-5-induced events. These
results reveal that Tg-sensitive Ca2þ stores and Ca2þ entry
are each responsible in part for the observed K6PC-5-induced
[Ca2þ ]i signaling, which is independent of the PLC/IP3
pathway.
K6PC-5 increases differentiation-related marker proteins in
keratinocytes
To determine whether K6PC-5 as a SphK activator affects
keratinocytes differentiation through SphK-mediated S1P
production involving Ca2þ signaling, reverse transcriptase
PCR and western blotting were performed. K6PC-5 and
exogenous S1P increased the mRNA levels of keratinocyte
differentiation-associated marker proteins including involu-
crin and filaggrin in HaCaT cells (Figure 5a). The expression
levels of these proteins were also promoted by K6PC-5 and
S1P (Figure 5b).
K6PC-5-induced keratinocyte differentiation was further
investigated by using siRNA for SphK1 (siRNA-SphK1)-
transfected cells to confirm the functional consequences of
SphK-mediated S1P production by K6PC-5. SiRNA-SphK1
blocked the expression of involucrin as a differentiation
marker protein, whereas empty vector did not alter expres-
sion. Interestingly, extracellular S1P-induced differentiation
also was blocked in siRNA-SphK1-transfected cells (fourth
selection), suggesting that extracellular S1P induces SphK1-
mediated keratinocyte differentiation. These results suggest
that the effects of K6PC-5 are dependent on a S1P-related
mechanism through SphK1, correlating with the [Ca2þ ]i
responses induced by siRNA to SphK1 (cf. Figure 3).
K6PC-5 enhances production of differentiation marker proteins
in murine epidermis in vivo
To elucidate the potency of K6PC-5 in vivo, we used a well-
established hyperproliferative murine model, as reported
previously (Denda et al., 1996). Again, both K6PC-5 and S1P
accelerated the expression of differentiation-associated spe-
cific proteins, including involucrin, loricrin, filaggrin, and
keratin 5 (Figure 6a). These results correlate well with the
in vitro results above (cf. Figure 5), and suggest that K6PC-5
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Figure 3. K6PC-5-induced [Ca2þ ]i oscillations involved SphK1 activation in HaCaT cells. After treatment of 1 mM DMS or 1 mM DHS, 50 mM K6PC-5 was applied
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treatment(s) with indicated compounds.
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and S1P can promote epidermal differentiation in intact skin.
Topical treatment of K6PC-5 in normal hairless mice skin
yielded similar results (data not shown). Next, Ca2þ signaling
was also studied in vivo by topical treatment of intact hairless
mice skin with K6PC-5 and S1P. K6PC-5 increased the Ca2þ
mobilization, visualized by calcium green-1 fluorescence
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Figure 4. K6PC-5-induced [Ca2þ ]i oscillations were dependent on both Tg-sensitive Ca
2þ stores and Ca2þ entry, but not the PLC/IP3 pathway, in HaCaT
cells. Cells were exposed to 1mM Tg followed by 100 mM K6PC-5 (a, left). A complementary experiment was performed (a, right). 50 mM K6PC-5 containing
1.2 mM (solid) or 0 mM Ca2þ (dotted) was applied (b). After treatment with 50 mM K6PC-5, 75mM 2-APB (c, left) and 1 mM Gd3þ (c, right) were applied.
S1P-/K6PC-5-treated cells were also treated with 1 mM U73122 (solid) or 1 mM U73343 (dotted) as indicated by the arrow (U) (d).
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(Figure 6b), an increase that was eliminated by 3 hours. S1P
also yielded an equivalent result, although the effect was less
intense than that of K6PC-5. The difference of time and
intensity of K6PC-5 and S1P may reflect the relative
hydrophobicity of K6PC-5, which affects its penetration
through the intact stratum corneum (SC).
K6PC-5 decreases epidermal hyperplasia by inhibiting
keratinocyte proliferation
Prior studies have shown that repeated removal of either the
whole SC or the SC intercellular lipids results in an increased
epidermal thickness, stemming from increased keratinocytes
proliferation (Denda et al., 1996). To elucidate the possible
activity of K6PC-5 in certain skin disorders, we used this
hyperproliferative murine model. Both K6PC-5 and S1P
attenuated the increase in epidermal thickness induced by
sequential tape stripping (Figure 7a), and correspondingly
inhibited the increase of proliferating-cell nuclear antigen
(PCNA)-positive and proliferating keratinocytes (Figure 7c).
The hematoxylin and eosin images confirmed these results
(Figure 7b and d). We also performed viability, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT)
assays in HaCaT cells to confirm the antiproliferative effect of
K6PC-5 and S1P in vitro. K6PC-5 and S1P both significantly
inhibited keratinocyte proliferation in a dose-dependent
manner in HaCaT cells (Figure 7e). Together, these results
suggest that K6PC-5 and S1P decrease epidermal hyperplasia
by inhibiting keratinocytes proliferation.
DISCUSSION
We report results with a novel SphK1 activator, K6PC-5, on
Ca2þ signaling in human keratinocytes as well as epidermal
differentiation and proliferation in both cultured cells and
murine skin. The activation of SphK by K6PC-5 was revealed
while new chemicals derived from bioactive and short-chain
pseudoceramides were being developed to promote kerati-
nocyte differentiation (Kwon et al., 2007). However, K6PC-5
represents a compound with novel activities not anticipated
from its simple short-chain pseudoceramide structure. Thus,
this study is the first to report K6PC-5 as a small-molecule
SphK activator. K6PC-5 activated SphK obtained both from
C57BL/6 murine blood and from F9-12 cell lysates in a dose-
dependent manner, inducing conversion of C17-Sph to C17-
S1P. Since SphK1-knockout mice show no SphK activity in
whole blood (Venkataraman et al., 2006), and F9-12 cells
overexpress SphK1 (Kariya et al., 2005), these results reveal
K6PC-5 to be a direct activator of SphK1. In addition, K6PC-
5-induced [Ca2þ ]i oscillations in HaCaT cells were blocked
by SphK inhibitors, DMS, and DHS. Moreover, HaCaT cells
transfected with siRNA to SphK1 did not respond to K6PC-5.
These results further reveal that K6PC-5 is a direct activator of
SphK, especially SphK1. Distinct Ca2þ mobilization by
K6PC-5 also was evident in murine epidermis. In addition,
pertussis toxin and U73122 did not prevent [Ca2þ ]i oscilla-
tions by K6PC-5, but both of these compounds inhibited the
S1P-induced effects. These findings suggest that K6PC-5 can
enhance the role of S1P as an intracellular second messenger.
Although many activators of SphK have been identified, most
of them involve upstream cell-membrane receptors (Taha
et al., 2006). However, we have no evidence that K6PC-5
induces cellular response through a membrane receptor to
activate SphK. In fact, the hydrophobic property of K6PC-5
may allow easy passage into and through the cell membrane.
We therefore suggest that K6PC-5 is a unique compound
having direct effect(s) on SphK1 enzyme activity in human
epidermal keratinocytes.
S1P has been shown to operate via both PLC-dependent
and -independent pathways to increase Ca2þ signaling
(Meyer zu Heringdorf, 2004). Blom et al. (2005) also reported
recently that IP3 is the major Ca
2þ -releasing second
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Figure 5. K6PC-5 increased differentiation-related marker proteins in HaCaT cells. mRNA (a) and protein (b) levels of Involucrin (INV) and filaggrin (FIL), as
marker proteins of keratinocyte differentiation, induced by K6PC-5 and S1P, were measured by reverse transcriptase–PCR and western blotting, respectively. NC,
normal control. The expression of involucrin in siRNA-SphK1-transfected cells (fourth selection) was measured by western blotting (c).
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messenger in an exogenous S1P-stimulating system, effects
that are dependent on both PLC and the subsequent
generation of intracellular S1P. Additionally, endogenous
S1P also affects [Ca2þ ]i mobilization in human embryonic
kidney-293 cells. Although an intracellular target(s) for S1P
has/have yet to be identified, several investigations have
shown direct [Ca2þ ]i-mobilizing effects of intracellular
S1P (Ghosh et al., 1994; Meyer zu Heringdorf et al., 2003).
However, the mechanism of which intracellular S1P mobi-
lizes Ca2þ from intracellular stores also is unknown,
although a novel Ca2þ channel has been reported (Young
and Nahorski, 2001). Current studies reveal another possible
mechanism for these effects. Specifically, since K6PC-5-
induced Ca2þ response is dependent on both Tg-sensitive
Ca2þ stores and extracellular Ca2þ , and since both 2-APB
and Gd3þ prevented [Ca2þ ]i oscillations by K6PC-5,
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Figure 6. K6PC-5 enhanced production of differentiation marker proteins in murine epidermis in vivo. The expression levels of differentiation-associated
proteins induced by topical applications of 1% K6PC-5 and 1 mM S1P on hairless mouse skin were analyzed by immunohistochemistry (a). Involucrin (INV),
loricrin (LOR), filaggrin (FIL), and keratin 5 (K5) were used as marker proteins of epidermal differentiation. The image of K6PC-5-induced Ca2þ mobilization in
murine epidermis was measured by Calcium Green-1 (b). 1% K6PC-5 and 1 mM S1P were applied topically on hairless mouse skin, and tissue biopsies were
performed after application in 30 and 60 minutes, respectively.
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intracellular S1P produced by K6PC-5 appears to release
Ca2þ from intracellular stores using an alternate pathway.
The [Ca2þ ]i signal induced by K6PC-5 is distinct from the
classical PLC/IP3 pathway because these K6PC-5 effects are
independent of GiPCR and PLCb. Although K6PC-5 induced
S1P-evoked [Ca2þ ]i signaling, there was no evidence that
S1P binds directly to the IP3 receptor to release intracellular
Ca2þ into the cytoplasm. In fact, this effect may reflect
indirect Ca2þ signaling of intracellular S1P, which Blom et al.
(2005) previously suggested to explain results in their system.
The study of S1P-mediated events is challenging as it
functions both as an extracellular ligand for a family of five
G-protein-coupled receptors and an intracellular second
messenger (Spiegel and Milstien, 2003). Exogenous S1P
affects its receptors on the cell membrane, as its structural
characteristics preclude its direct penetration through cell
membranes. Conversely, since, as we have shown here,
K6PC-5 can readily penetrate cell membranes to activate
SphK1 and increase endogenous S1P levels, this novel
compound should be useful for studying the intracellular
roles and Ca2þ signals induced by S1P.
Vogler et al. (2003) previously reported that S1P enhances
differentiation of cultured keratinocytes and possesses anti-
proliferative effect that protects cells from programmed
cell death. Kim et al. (2004) also showed that S1P inhibits
human keratinocyte proliferation via Akt/protein kinase B
inactivation. Therefore, we anticipated similar effects of
K6PC-5 on keratinocytes via its induction of S1P levels. We
show that K6PC-5 and S1P increased mRNA and protein
levels of involucrin and filaggrin as specific differentiation
markers in HaCaT cells, and that siRNA-SphK1 blocked the
expression of involucrin induced by K6PC-5 and S1P. Their
respective protein expression is elevated by K6PC-5 topical
treatment in murie epidermis. Interestingly, exogenous S1P
also yielded similar results. Moreover, using an established
in vivo model, the hyperplasia induced by tape stripping in
hairless mouse epidermis was significantly inhibited by both
K6PC-5 and S1P, with a corresponding inhibition of PCNA
staining. These results reveal that K6PC-5 and S1P have anti-
proliferative effect on the epidermis of murine skin under
hyperproliferative conditions.
Although the extent to which impaired epidermal pro-
liferation plays a role in the pathogenesis of certain skin
diseases remains a topic of debate, the present results suggest
that the regulation of S1P levels may represent a useful, novel
approach for the treatment for such a skin disease by
regulating both epidermal differentiation and proliferation.
Interestingly, K6PC-5 increased expression of specific differ-
entiation-associated marker proteins, which are downregu-
lated in the skin of atopic patients including K5, K10,
involucrin, and filaggrin (Jensen et al., 2004). Moreover
K6PC-5 decreases the epidermal thickness and PCNA-positive
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cells in a murine hyperproliferative model. Together, these
findings suggest that S1P represents an attractive sphingolipid
for the regulation of both differentiation and proliferation of
epidermal keratinocytes.
MATERIALS AND METHODS
Materials
Adult female hairless mice, 8–10 weeks of age, were purchased from
the animal laboratory of Yonsei University (Seoul, Korea). The use of
animals was approved by the institutional review board of Yonsei
University College of Medicine. Ciglitazone was purchased from
Cayman Chemical Laboratories (Ann Arbor, MI); troglitazone was
from Biomol Laboratories (Plymouth, PA). Affinity-purified rabbit
primary antibodies specific for human SphK1 were purchased from
BabCo (Richmond, CA); mouse filaggrin, loricrin, and involucrin
were from Covance Research (Berkeley, CA); keratin 5 and PCNA
were from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary
goat anti-rabbit IgG-HRP and diaminobenzidine were from Dako-
Cytomation (Glostrup, Denmark). All reagents for reverse transcrip-
tase–PCR were from Takara Korea Biomedical (Otsu, Japan).
Fluorescein-FragEL apoptosis detection kit was from Oncogen
Research Products (San Diego, CA). S1P, thapsigargin, 2-APB),
U73122, U73343, G-418, and pertussis toxin were purchased from
Sigma (St Louis, MO); RPMI 1640, penicillin, streptomycin, and fetal
bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA);
fura2-acetoxymethyl ester was purchased from Teflabs (Austin, TX).
C17-Sph and C17-S1P were obtained from Avanti Polar Lipid Inc.
(Alabastar, AL). o-Phthalaldehyde was obtained from Nacalai Tesque
(Kyoto, Japan). All other chemicals were of reagent grade.
SphK activity
Mouse blood from C57BL/6 mice was used as the source of SphK.
The mice (4–6 weeks old) were obtained from Jackson Laboratories
(Bar Harbor, ME). Whole blood was collected in acid-citrate buffer
(0.1 ml ml1 of blood) and heparin (50 U ml1 blood) via cardiac
puncture following avertin anesthesia, and diluted with 900ml of 4
SphK assay buffer (0.5 M HEPES–KOH, 1 M NaF, 1 M b-glyceropho-
sphate, 1 M orthovanadate, 10% Triton X-100, 1 M MgCl2) to a total
volume of 1.0 ml (Dil-blood). A 1-ml volume of K6PC-5 from the
stock solution (dissolved in DMSO) was added to each tube (Dil-
blood 50 ml, 4 SphK assay buffer 25 ml, 1 mM C17-Sph 1ml, 10 mM
ATP 1ml, water 22 ml) for 30 minutes at 37 1C to measure SphK
activity. The phosphorylation reaction was terminated by addition of
200ml of MeOH and solutions were stored at 80 1C until S1P
analysis. Quantification of C17-S1P was performed using
high-performance liquid chromatography with fluorescence detec-
tion, as previously described (Min et al., 2002). The SphK activity is
reported as the picomoles of C17-S1P formed per minute per mg of
protein.
SphK activity was determined in F9-12 cells according to the
method reported previously(Jin et al., 2006). Briefly, F9-12 cell
lysates were prepared and 30 mg of cell lysate were incubated
20 minutes at 37 1C with 100mM C17-Sph in 5% Triton X-100, 10 mM
ATP solution, and K6PC-5, and terminated by addition of 1 N HCl
and 0.8 mM CHCl3/methanol/HCl (100:200:1, v/v) at 4 1C. Samples
were vigorously vortexed and centrifuged after adding 200 pmol
C17-S1P as an internal standard. The CHCl3 phase was extracted
with 2 M NaCl, followed by H2O phase extraction with 3 N NaOH to
obtain C17-S1P. The alkaline aqueous phase containing C17-S1P
was mixed thoroughly with dephosphorylating reaction buffer
(200 mM Tris-HCl (pH 7.4), 75 mM MgCl2 in 2 M glycine buffer, pH
9) and 50 U of alkaline phosphatase, and incubated for 1 hour at
37 1C. Dephosphorylated C17-Sph was extracted with CHCl3,
washed with alkalinized water (pH 10), and dried. For high-
performance liquid chromatography analysis, the residue was
dissolved in EtOH and incubated with the o-phthalaldehyde
reagent (50 mg of o-phthalaldehyde, 1 ml of ethanol, 100 ml of
2-mercaptoethanol, and 50 ml of 3% (w/v) boric acid solution) for
10 minutes at 50 1C. After the derivatization process, the
o-phthalaldehyde derivative of C17-Sph was used for high-perfor-
mance liquid chromatography analysis of C17-S1P. SphK activity
was calculated from newly synthesized C17-S1P and expressed
as pmol mg1 min1.
Cell culture
Mouse embryonic carcinoma F9-12 cells were kindly supplied by
Hokkaido University, Japan. Cells were cultured in DMEM
supplemented with 10% FBS and 1% penicillin–streptomycin for
SphK activity measurement.
HaCaT cells were purchased from American Type Culture
Collection (Manassas, VA) and were cultured in RPMI 1640
supplemented with 2 mM glutamine, 25 mM HEPES buffer,
100mg ml1 penicillin, 25 ng ml1 streptomycin, and 10% FBS. For
[Ca2þ ]i measurements, cells were seeded in 60-mm culture dishes
and maintained at 37 1C under a humidified atmosphere of 5% CO2
and 95% air to 80% confluence. The cells were serum-starved for
24 hours before each experiment.
For HaCaT differentiation, cells were cultured in DMEM
supplemented with 10% FBS. For treatment with K6PC-5 and S1P,
approximately 1 106 cells were seeded on 100-mm culture dishes
at approximately 80% confluence. Cells were starved of serum for
24 hours and treated with K6PC-5 or S1P in serum-free medium.
Keratinocyte proliferation
The effect of K6PC-5 or S1P on keratinocyte viability was determined
using MTT assay. HaCaT cells (1 104 cells well1) were seeded in
96-well plates in DMEM with 5% FBS for 48 hours, and incubated
with K6PC-5 or S1P in DMEM serum-free media for 24 hours at
37 1C. After addition of 20 ml well1 of MTT solution (10 mg ml1 in
phosphate-buffered saline), plates were incubated for 4 hours at
37 1C. Supernatants were then removed and formazan crystals were
dissolved in 100 ml of dimethylsulfoxide. Optical density was
determined at 540 nm using a microplate reader (SpectraMax
340PC; Molecular Device Co., Sunnyvale, CA).
Intracellular Ca2þ ([Ca2þ ]i) measurement in HaCaT cells
Cells were loaded with 3.5 mM fura2-acetoxymethyl ester for 1 hour
at room temperature in PSS containing 140 mM NaCl, 5 mM KCl,
1.2 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, and 10 mM glucose, and
titrated to pH 7.4 with NaOH. Ca2þ -free PSS contained 1 mM EDTA
and 1 mM ethyleneglycol-bis-(b-aminoethylether)-N,N,N,N-tetraace-
tic acid, without CaCl2. The fura2-acetoxymethyl ester-loaded cells
were mounted into the chamber of an inverted microscope (Nikon,
Tokyo, Japan) for calcium imaging. Excitation wavelength was
alternated between 340 and 380 nm, and emission wavelength was
monitored at 510 nm with a CCD camera using MetaFlour system
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(Universal Imaging Co., Downingtown, PA). Fluorescence images
were obtained at 3-second intervals. Background fluorescence was
subtracted from the raw intensity at each excitation wavelength.
Ca2þ mobilization in murine epidermis
The effect of K6PC-5 on Ca2þ mobilization in epidermis was
visualized using a method reported previously (Denda et al., 2000).
An agarose-gel membrane (2%) containing 10 mg ml1 Calcium
Green 1 (Molecular Probes, Eugene, OR) was formed on the slide,
and a frozen section of whole skin (8-mm thick) was placed directly
on the gel membrane. A fluorescence photomicrograph was taken
within 2 hours with an excitation wavelength of 546 nm.
siRNA downregulation of SphK1 expression
siRNA-SphK1 was constructed using the psiSTRIKE vector system
(Promega, Madison, WI). The siRNA-SphK1 target-specific se-
quences were sense, 50-ACCGCGGGTCGAGGTTATGGATTTCAA
GAGAATCCATAACCTCGACCCGCTTTTTC-30 and reverse, 50-GCA
GAAAAAGCGGGTCGAGGTTATGGATTCTCTTGAAATCCATAACC
TCGACCCG-30. The scramble-SphK1 sequences were forward, 50-
ACCGGAGTCAGTCTGGGTATGGTTCAAGAGACCATACCCAGAC
TGACTCCTTTTTC-30 and reverse, 50-TGCAGAAAAAGGAGTCAG
TCTGGGTATGGTCTCTTGAACCATACCCAGACTGACTC-30. Cells
were co-transfected with siRNA-SphK1 (1mg ml1) and green
fluorescent protein (eGFP-N1) (1 mg ml1) using Lipofectamine
2000 reagent (Invitrogen), and cultured for 48 hours in serum-free
RPMI 1640 including opti-MEM; cells were selected using G-418
(Invitrogen). Depletion of endogenous SphK1 by siRNA was
confirmed by reverse transcriptase–PCR in first-/sixth-selected cells
and Western blotting in sixth-selected cells. To check the functional
effect of siRNA, [Ca2þ ]i were measured in third-selected cells. To
clarify the transfection of siRNA, same target specific sequences
were re-constructed using the hMGFP-siRNA vector to measure
[Ca2þ ]i by the same manufacturer’s directions (Promega). The
hMGFP vector system used only to confirm with GFP fluorescence of
transfected cells.
Reverse transcriptase–PCR
Total RNA was extracted from cultured HaCaT cells using Trizol
reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s
protocol. Equal amounts of RNA (2 mg) were reverse-transcribed
using an RNA PCR kit (AMV) (Takara, Otsu, Japan). Semi-
quantitative PCR was performed using the following specific
primers: human SphK1 (50-ATGGATCCAGTGGTCGGTTG-30 and
50-TCTTCATTGGTGACCTGCT-30); human involucrin (50-GGACG
GACAACTAAAACAT-30 and 50-AGCGGACCCGAAATAAG-30); hu-
man filaggrin (50-GTTCACATTTATTGCCAAAAGA-30 and 50-GAG
CCAACTTGAATACCAT-30); and glyceraldehyde-3-phosphate dehy-
drogenase as an internal control (50-TGAGCTGAACGGGAAG-30
and 50-CTGTAGCCAAATTCGTTGT-30). cDNAs, SphK1, involucrin,
filaggrin, glyceraldehyde-3-phosphate dehydrogenase, and b-actin
were amplified using 35, 35, 40, 30, 25, and 30 cycles, respectively.
Reaction products were separated in 2% agarose gels and visualized
with ethidium bromide.
Western immunoblotting
Cells were lysed in protein extraction reagent (Pierce Biotechnology
Inc., Rockford, IL). Lysates were centrifuged at 12,000 g for
15 minutes and supernatants were collected for western immuno-
blotting. Protein concentrations were determined using the BCA
assay (Pierce, Rockford, IL). Equal protein amounts (20 mg) were
separated by 10% SDS-PAGE and blotted onto polyvinylidene
difluoride membranes. Membranes were subsequently blocked with
5% skimmed milk in TBS-T (20 mM Tris-HCl, pH 7.6; 137 mM NaCl;
0.1% Tween 20) and incubated sequentially with primary antibody
(3 hours), followed by horseradish peroxidase-conjugated secondary
antibody (2 hours), at room temperature. Blotting proteins were
visualized by enhanced chemiluminescence (Pierce).
Animal model for epidermal hyperplasia
Epidermal hyperproliferation was achieved by repeated applications
of D-squames to the flanks of hairless mice twice daily for 5 days
until transepidermal water loss reached 40 mg cm2 hour1 as
determined with Tewameter (Courage and Khasaki, Cologne,
Germany) (Denda et al., 1996). After each tape-stripping sequence,
animals (n¼ 5 in each group) were treated with 1.0% K6PC-5, or
1 mM S1P dissolved in propylene glycol:ethanol (7:3 ratio), or
vehicle alone to one flank, twice daily, for the last 3 days. A third
group consisted of control non-tape-stripped, non-treated animals
(n¼ 3). Harvesting of tissue samples was performed 6 hours after the
last treatment.
Microscopy and imaging
Skin samples were fixed in 10% formalin. Three-to-five images of
6-mm-thick paraffin sections stained with hematoxylin and eosin
were obtained using a Zeiss Axioplan 2 microscope (Jena, Germany)
at  200 magnification. Epidermal thickness, considered as the
distance from the basal layer to the stratum granulosum/SC junction,
was randomly measured on 10 points in each image field, with mean
values presented for each sample (Demerjian et al., 2006).
Immunohistochemistry
Paraffin-embedded sections of hairless mice skin biopsies were used
for immunohistochemistry, with specific antibodies for involucrin,
loricrin, filaggrin, and keratin 5. After deparaffinization and
rehydration, sections were incubated with peroxidase blocking
reagent (DakoCytomation, Glostrup, Denmark) for 30 minutes to
block endogenous peroxidase activity. Nonspecific antibody activity
was blocked by incubation with serum-free protein block (Dako-
Cytomation) for 15 minutes at room temperature; the primary
antibodies (anti-involucrin, anti-loricrin, anti-filaggrin, 1:500 (Cov-
ance Research); and anti-K5, 1:500 (Santa Cruz Biotechnology) were
applied for 30 minutes at 37 1C, followed by horseradish peroxidase-
conjugated secondary antibody (30 minutes) at room temperature.
Staining for these proteins was detected by diaminobenzidine as the
substrate. Proliferating keratinocytes were visualized with anti-
PCNA antibodies, following the same method to detect proliferating
cells. PCNA-positive cells were counted in the basal and supra-basal
layers in five images from each section ( 200 magnification).
Statistics
All data are expressed as mean±SEM. Statistical significance was
determined by two-tailed Student’s t-test.
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